"Glucocorticoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
Descriptor ID |
D005938
|
MeSH Number(s) |
D06.472.040.543 D27.505.696.399.472.488
|
Concept/Terms |
Glucocorticoid Effect- Glucocorticoid Effect
- Effect, Glucocorticoid
- Glucorticoid Effects
- Effects, Glucorticoid
|
Below are MeSH descriptors whose meaning is more general than "Glucocorticoids".
Below are MeSH descriptors whose meaning is more specific than "Glucocorticoids".
This graph shows the total number of publications written about "Glucocorticoids" by people in this website by year, and whether "Glucocorticoids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2000 | 0 | 2 | 2 |
2001 | 0 | 1 | 1 |
2002 | 2 | 1 | 3 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 4 | 2 | 6 |
2006 | 4 | 1 | 5 |
2007 | 1 | 1 | 2 |
2008 | 1 | 3 | 4 |
2009 | 6 | 0 | 6 |
2010 | 3 | 1 | 4 |
2011 | 1 | 4 | 5 |
2012 | 2 | 2 | 4 |
2013 | 0 | 2 | 2 |
2014 | 3 | 1 | 4 |
2015 | 2 | 0 | 2 |
2016 | 6 | 2 | 8 |
2017 | 67 | 72 | 139 |
2018 | 76 | 77 | 153 |
2019 | 20 | 23 | 43 |
2020 | 47 | 73 | 120 |
2021 | 31 | 36 | 67 |
To return to the timeline, click here.
Below are the most recent publications written about "Glucocorticoids" by people in Profiles.
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
-
Phlyctenular Keratoconjunctivitis in a Patient With COVID-19 Infection. Cornea. 2021 Nov 01; 40(11):1502-1504.
-
Pulse steroid treatment for hospitalized adults with COVID-19 Turk J Med Sci. 2021 10 21; 51(5):2248-2255.
-
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy. Rheumatology (Oxford). 2021 10 09; 60(SI):SI25-SI36.
-
Clinical Features, Laboratory, and Radiological Findings of Patients With Acute Inflammatory Myelopathy After COVID-19 Infection: A Narrative Review. Am J Phys Med Rehabil. 2021 10 01; 100(10):919-939.
-
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study. PLoS One. 2021; 16(9):e0256977.
-
Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Curr Opin Rheumatol. 2021 09 01; 33(5):412-418.
-
COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology Turk J Ophthalmol. 2021 08 27; 51(4):231-242.
-
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6).
-
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients. Clin Exp Nephrol. 2022 Jan; 26(1):75-85.